The markets are trading lower this morning, but after Monday's Ben Bernanke easy-money-fueled run, a slight retracement is not surprising. We should also take a moment to congratulate delicious organic foods purveyor Annie's
Let's take a closer look at how the major indexes are doing and some individual stocks making headlines.
Gain / Loss
Gain / Loss %
Dow Jones Industrial Average
Source: Yahoo! Finance.
Oral arguments over the Affordable Care Act continue at the Supreme Court. Today, the court is hearing arguments over the constitutionality of the whole act, not just the individual mandate, which it heard yesterday. If the act is upheld as law, but the individual mandate ruled unconstitutional, it could be disastrous for insurers since they would be forced to cover high-risk populations without balancing it out with the low-risk pool that generally avoids insurance. Insurers will likely spread these higher costs to their customers via higher premiums, further incentivizing citizens to stay off insurance until they get sick. Although health-care providers don't affect the Dow, the Supreme Court's eventual decision will have a wide ranging impact across the economy.
Stealing headlines: biotech Amylin
A better approach
Instead of waiting and watching for a Supreme Court decision to invest in health care, why not follow Motley Fool co-founder David Gardner's lead? He recently identified a small-cap health-care company that is poised for monster returns, regardless of what happens to the law. To uncover this top pick today, take a look at our special free report, "Discover the Next Rule-Breaking Multibagger." Don't miss out on this limited-time offer and your opportunity to discover this game-changing company before the market does. Access your report -- it's totally free.
David Williamson holds no position in any company mentioned. Click here to see his holdings and a short bio. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.
More from The Motley Fool
Does a Strong Start Make 2018 a Sure Winner for Stocks?
Find out whether the so-called "January effect" is real.
Meet the 2018 Dogs of the Dow
Learn the basics of this simple dividend-investing strategy.
The Dow's Worst Day in 2017
Even with big gains, there were some scary times for the average.